/ Kills / LIBIDO KILL
LIBIDO KILL
“Kill dead libido. Not your marriage.”
// 01
Summary.
Central-pathway sexual-function protocol. Unlike PDE5 inhibitors, these act on desire rather than plumbing. Clinician-gated — hormone panels come first, always.
Before any of this: get a morning total and free testosterone, SHBG, estradiol, prolactin, TSH and a fasting glucose. Low drive is a symptom. Most of the time the lab explains it.
// 02
The stack.
Peptide · 01
PT-141
Bremelanotide · melanocortin agonist
Central desire pathway. Not vascular.
10 mg / vial
Peptide · 02
KISSPEPTIN-10
Upstream GnRH signalling
Acts above the hypothalamic-pituitary axis.
5 mg / vial
Peptide · 03
OXYTOCIN
Neuropeptide
Bonding, arousal and post-orgasmic state.
nasal / SubQ
// 03
Reconstitution.
Dosing for this protocol is prescriber-managed.
PT-141 in particular causes nausea and blood-pressure changes
at doses people commonly self-select.
We publish the framework, the lab work-up and the
registry outcomes — not a self-dosing card.
Ask your clinician.
// 04
Dosing table.
| Level | Stack | Units (U-100) | Freq |
|---|---|---|---|
| CLINICIAN | PT-141 | prescriber-set | As needed |
| CLINICIAN | KISSPEPTIN-10 | prescriber-set | Protocol-dependent |
| CLINICIAN | OXYTOCIN | prescriber-set | As needed |
// 05
Cycle & timing.
WORK-UP
FIRST
Full hormone panel before anything. Low drive is a symptom, not a diagnosis.
AS NEEDED
EPISODIC
This is not a daily protocol. Episodic use, prescriber-managed.
// 06
Contraindications.
- —Uncontrolled hypertension — PT-141 raises blood pressure transiently.
- —Cardiovascular disease without clearance.
- —Pregnancy / lactation.
- —Untreated hypogonadism — treat the cause first.
- —This lane requires a prescriber. Do not self-source.
// 07
Evidence.
CLINICAL
Bremelanotide (PT-141) has an FDA-approved indication for hypoactive sexual desire disorder in premenopausal women. Everything else here is off-label or investigational.
KISSPEPTIN
Human data is early and mostly academic. Promising mechanism, thin outcome literature.
FIRST
The highest-yield intervention in this category is a hormone panel and honest sleep, not a peptide.
// 09
Adverse events.
MILD
0
MODERATE
0
SEVERE
0
// 10
Related kills.
RECOVERY KILL
“Heal like you borrowed the body.”
SLEEP KILL
“Die better at night.”
FAT KILL
“Not a diet. A vendetta.”
// Disclaimer
Nothing on killer.health is medical advice. This platform is a research registry and information aggregator. Content is drawn from peer-reviewed publications, clinical protocols and community sources. killer.health does not endorse any compound, supplier or treatment. Always work with a licensed physician inside an established clinical relationship before starting, stopping or modifying any protocol. Data capture is governed by IRB PPRN-001-2025. Anonymous submissions are the default.